WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000058365) SPECIFIC BINDING PROTEINS FOR TREATING CANINE ALLERGY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/058365    International Application No.:    PCT/US2000/008347
Publication Date: 05.10.2000 International Filing Date: 30.03.2000
IPC:
C07K 16/42 (2006.01)
Applicants: IDEXX LABORATORIES, INC. [US/US]; One Idexx Drive, Westbrook, ME 04092 (US) (For All Designated States Except US).
LAWTON, Robert [US/US]; (US) (For US Only).
MERMER, Brion [US/US]; (US) (For US Only).
FRANCOEUR, Greg [US/US]; (US) (For US Only)
Inventors: LAWTON, Robert; (US).
MERMER, Brion; (US).
FRANCOEUR, Greg; (US)
Agent: CONSALVI, Mary, S.; Howrey Simon Arnold & White, LLP, 1299 Pennsylvania Avenue, N.W., Washington, DC 20004-2402 (US)
Priority Data:
09/281,760 30.03.1999 US
Title (EN) SPECIFIC BINDING PROTEINS FOR TREATING CANINE ALLERGY
(FR) PROTEINES DE LIAISON SPECIFIQUES POUR LE TRAITEMENT D'ALLERGIES
Abstract: front page image
(EN)Disclosed are binding proteins that specifically bind to an isolated and purified peptide comprising a leucine positioned two peptide bonds away from a tyrosine-arginine pair. Other binding proteins of the invention include those that specifically bind to an isolated and purified peptide with the sequence cysteine-blank-blank-proline-histidine-blank-blank-blank-cysteine (SEQ ID NO:6) or cysteine-blank-proline-histidine-blank-proline-blank-blank-cysteine (SEQ ID NO:9).
(FR)Cette invention concerne des protéines de liaison qui se lient spécifiquement l un peptide isolé et purifié comprenant une leucine positionnées entre duc liaisons peptidiques à l'écart d'une paire tyrosine-arginine. Parmi les autres protéines de liaison selon l'invention figure celles qui se lient spécifiquement à une peptide isolée et purifiée avec la séquence cystéine-blanc-blanc-proline-histidine-blanc-blanc-blanc-cystéine (SEQ ID NO:6) ou cystéine-blanc-proline-histidine-blanc-proline-blanc-blanc-cystéine (SEQ ID NO:9).
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)